Abiomed, Inc.

Abiomed Expands Availability of Impella Circulatory Support Technologies with Regulatory Approvals in India

Published in Health Business Week, April 13th, 2007

Abiomed, Inc. (NASDAQ: ABMD) announced that the Office of the Drug Controller General (DCGI) in India has granted registration for the Company's Impella 2.5 and Impella 5.0 circulatory support technologies. Abiomed plans to market these advanced medical devices through Interventional Technologies, Ltd, its distributor based in Mumbai, India.

"We are excited that interventional cardiologists in India will now have the opportunity to treat heart failure patients with the Impella circulatory support technologies," said V.M. Kasim, Chairman & Managing Director, Interventional Technologies, Ltd., India.

The Impella 2.5 is a ventricular assist catheter,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry